Mirae Asset Global ETFs Holdings’s Apogee Therapeutics APGE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.37M	Sell	32,927 -1,290	-4%	-$116K	0.01%	909
2026 Q1	$2.86M	Buy	34,217 +13,508	+65%	+$981K	﹤0.01%	1033
2025 Q4	$1.56M	Buy	20,709 +2,130	+11%	+$134K	﹤0.01%	1273
2025 Q3	$738K	Sell	18,579 -976	-5%	-$37.3K	﹤0.01%	1674
2025 Q2	$849K	Sell	19,555 -4,974	-20%	-$189K	﹤0.01%	1534
2025 Q1	$921K	Buy	24,529 +694	+3%	+$26.8K	﹤0.01%	1545
2024 Q4	$1.08M	Buy	23,835 +931	+4%	+$47.5K	﹤0.01%	1504
2024 Q3	$1.34M	Sell	22,904 -1,065	-4%	-$51K	﹤0.01%	1368
2024 Q2	$945K	Buy	+23,969	New	+$1.16M	﹤0.01%	1485

Other funds holding APGE

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's APGE Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Apogee Therapeutics (APGE) stake by 3.8% in Q2 2026, selling an estimated $116K and leaving 32,927 shares worth $4.37M. The position accounts for 0.01% of the portfolio, ranked #909.

Mirae Asset Global ETFs Holdings first reported a position in APGE in Q2 2024 and has held it in 9 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

Mirae Asset Global ETFs Holdings held 32,927 shares of Apogee Therapeutics worth $4.37M as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 1,290 Apogee Therapeutics shares in Q2 2026, an estimated $116K.
Apogee Therapeutics made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #909 holding.
Mirae Asset Global ETFs Holdings first reported a position in Apogee Therapeutics in Q2 2024 and has held it in 9 quarters since.
289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.